CLINICAL NOTES
Abstract
Although the number of cases is admittedly small, the results seem to indicate that 0.5 cc. of hyaluronidase solution, containing 150 TR units per cc., when injected subcutaneously into any area of pain and swelling following intravenous injection of 50% glucose, is sufficient to reduce the usual 1-or 2-week course of the condition to 1 or 2 days.
This treatment also seems to prevent the development of such complications as progressive cellulitis, lymphangitis, and thrombophlebitis in such areas.
For best results, the hyaluronidase should be injected as soon as possible after the development of the swelling, but delayed treatment, for as much as 48 hours, still seems to have some benefit.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
